In conclusion, the results suggested that EVA1A ameliorated cardiac remodeling through inhibiting cardiac hypertrophy and fibrosis by promoting autophagy via inhibiting mTOR pathway [1]. Here, EVA1A is linked to cardiac hypertrophy.